filmov
tv
In adolescents, oral Truvada and vaginal ring for HIV prevention are safe, acceptable
Показать описание
A monthly vaginal ring and a daily oral tablet, both containing anti-HIV drugs, were safe and acceptable in studies of adolescents, two teams of investigators reported at the 9th IAS Conference on HIV Science in Paris. The experimental ring is designed for HIV prevention and the oral tablet is already used for this purpose in adults. National Institute of Allergy and Infectious Diseases, Divisions of AIDS Director Dr. Carl Dieffenbach talks about the studies.
In adolescents, oral Truvada and vaginal ring for HIV prevention are safe, acceptable
HIV Prevention in Adolescents - Sybil Hosek, PhD
PrEP and PEP: HIV Prevention
Session 6 | Oral Abstract Session 3 - Adolescents and HIV
Long-Acting HIV Prevention in Adolescents: Possibilities and Challenges - Mina Hosseinipour
Wise Bodies: Protect with PEP and PrEP
PrEP Use and Adherence among Adolescents
The “Dtgs” of DTG for Children and Adolescents Living with HIV (CALHIV): ... | Jason Bacha
HIV in the Adolescent Patient by R. Chakraborty | OPENPediatrics
10 Things You Need to Know about Daily PrEP
SESSION 2, ABSTRAT PRESENTATION #01 Yager, Jenna
STDP2020 - Oral 03 - Get PrEPped for STI Prevention
AIDS 2020 Summary: Children, Adolescents and HIV/COVID-19
Five Tips to Prevent HIV
#2 - One Year Outcome of Bictegravir/Emtricitabine/Tenofovir Alafenamide (...) - Carina A. Rodriguez
Efficacy and Safety of the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in... - Cindy Vavro
Session 6 | Oral Abstracts Session 5 - Prevention of HIV Mother-to-Child Transmission
How Long Does It Take For Truvada To Work
How Truvada works
HIV PrEP for Adolescents and Young Adults
Preliminary Safety, Efficacy, and Acceptability of Bictegravir/Emtricitabine (..) - Carina Rodriguez
In-Utero Exposure to High Tenofovir Concentration Is Associated With Lower Bone (..) - Kimesh Naidoo
Relationship with pills and injections - friend or foe - Biomedical interventions... - Allison Agwu
Overview of Clinical Data | Mina Hosseinipour, MD, MPH
Комментарии